Klammer M - Search Results

1

Global phosphoproteome analysis of human bone marrow reveals predictive phosphorylation markers for the treatment of acute myeloid leukemia with quizartinib.

Schaab C, Oppermann FS, Klammer M, Pfeifer H, Tebbe A, Oellerich T, Krauter J, Levis M, Perl AE, Daub H, Steffen B, Godl K, Serve H. Schaab C, et al. Among authors: klammer m. Leukemia. 2014 Mar;28(3):716-9. doi: 10.1038/leu.2013.347. Epub 2013 Nov 19. Leukemia. 2014. PMID: 24247654 Free PMC article. No abstract available.

2

Comparison of SILAC and mTRAQ quantification for phosphoproteomics on a quadrupole orbitrap mass spectrometer.

Oppermann FS, Klammer M, Bobe C, Cox J, Schaab C, Tebbe A, Daub H. Oppermann FS, et al. Among authors: klammer m. J Proteome Res. 2013 Sep 6;12(9):4089-100. doi: 10.1021/pr400417g. Epub 2013 Aug 16. J Proteome Res. 2013. PMID: 23898821

3

Identifying differentially regulated subnetworks from phosphoproteomic data.

Klammer M, Godl K, Tebbe A, Schaab C. Klammer M, et al. BMC Bioinformatics. 2010 Jun 28;11:351. doi: 10.1186/1471-2105-11-351. BMC Bioinformatics. 2010. PMID: 20584295 Free PMC article.

4

Phosphosignature predicts dasatinib response in non-small cell lung cancer.

Klammer M, Kaminski M, Zedler A, Oppermann F, Blencke S, Marx S, Müller S, Tebbe A, Godl K, Schaab C. Klammer M, et al. Mol Cell Proteomics. 2012 Sep;11(9):651-68. doi: 10.1074/mcp.M111.016410. Epub 2012 May 21. Mol Cell Proteomics. 2012. PMID: 22617229 Free PMC article.

5

Pareto Optimization Identifies Diverse Set of Phosphorylation Signatures Predicting Response to Treatment with Dasatinib.

Klammer M, Dybowski JN, Hoffmann D, Schaab C. Klammer M, et al. PLoS One. 2015 Jun 17;10(6):e0128542. doi: 10.1371/journal.pone.0128542. eCollection 2015. PLoS One. 2015. PMID: 26083411 Free PMC article.

6

Systematic evaluation of label-free and super-SILAC quantification for proteome expression analysis.

Tebbe A, Klammer M, Sighart S, Schaab C, Daub H. Tebbe A, et al. Among authors: klammer m. Rapid Commun Mass Spectrom. 2015 May 15;29(9):795-801. doi: 10.1002/rcm.7160. Rapid Commun Mass Spectrom. 2015. PMID: 26377007

7

Global quantitative phosphoproteome analysis of human tumor xenografts treated with a CD44 antagonist.

Weigand S, Herting F, Maisel D, Nopora A, Voss E, Schaab C, Klammer M, Tebbe A. Weigand S, et al. Among authors: klammer m. Cancer Res. 2012 Sep 1;72(17):4329-39. doi: 10.1158/0008-5472.CAN-12-0136. Epub 2012 Jul 9. Cancer Res. 2012. PMID: 22777824

8

Comparative proteome analysis across non-small cell lung cancer cell lines.

Grundner-Culemann K, Dybowski JN, Klammer M, Tebbe A, Schaab C, Daub H. Grundner-Culemann K, et al. Among authors: klammer m. J Proteomics. 2016 Jan 1;130:1-10. doi: 10.1016/j.jprot.2015.09.003. Epub 2015 Sep 8. J Proteomics. 2016. PMID: 26361996

9

Identification of significant features by the Global Mean Rank test.

Klammer M, Dybowski JN, Hoffmann D, Schaab C. Klammer M, et al. PLoS One. 2014 Aug 13;9(8):e104504. doi: 10.1371/journal.pone.0104504. eCollection 2014. PLoS One. 2014. PMID: 25119995 Free PMC article.

10

Quantitative Phosphoproteomics Analysis of ERBB3/ERBB4 Signaling.

Wandinger SK, Lahortiga I, Jacobs K, Klammer M, Jordan N, Elschenbroich S, Parade M, Jacoby E, Linders JT, Brehmer D, Cools J, Daub H. Wandinger SK, et al. Among authors: klammer m. PLoS One. 2016 Jan 8;11(1):e0146100. doi: 10.1371/journal.pone.0146100. eCollection 2016. PLoS One. 2016. PMID: 26745281 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

68 results

Search Page

Filters